آخر تحديث: أغسطس 15, 2026
Syphilis is one of the sexually transmitted infections I see regularly. How it presents depends on the stage — a painless genital ulcer early on, a rash on the palms and soles later. A blood test is the only way to confirm the diagnosis, and that is where the confusion starts, because there are two different families of blood test and each has its own strengths and limits.
This matters more than a technical detail. Patients who receive a positive result without a full explanation often leave badly frightened, and end up going from clinic to clinic looking for a second opinion that says something different. Understanding what each test actually measures usually removes the fear entirely.

1. Nontreponemal tests — the screening tests
These are used first, when syphilis is suspected. Their strength is that they reflect active infection, which also makes them the tests used to check whether treatment is working.
- VDRL (Venereal Disease Research Laboratory)
- RPR (Rapid Plasma Reagin)
Their weakness is that they can turn positive when there is no syphilis at all — a biological false positive, which several other conditions can cause. That is precisely why a positive screening test is never the end of the story. They can also read falsely negative very early in infection, before antibodies have developed, so a recent exposure with a negative result may need repeating.
2. Treponemal tests — the confirmation tests
If a VDRL or RPR comes back positive, the diagnosis has to be confirmed with a treponemal test.
- TP-PA (Treponema Pallidum Particle Agglutination)
- FTA-ABS (Fluorescent Treponemal Antibody Absorbed)
These are highly accurate for syphilis. Their limitation is the one that causes the most distress: a treponemal test stays positive for the rest of your life, even after the infection has been completely cured. It tells you that you have encountered syphilis at some point — not that you have it now. This is why treatment can never be judged by a treponemal test alone.
Reading the two together
The practical rule is simple once you have it: the confirmation test answers whether it was ever syphilis, and the screening test answers whether it is active now and whether the treatment is working. Treatment response is followed by watching the VDRL or RPR titre fall over the months after treatment. A permanently positive treponemal test alongside a falling titre is exactly what a successfully treated patient looks like.

Two practical points that follow from all this. A confirmed diagnosis means current sexual partners need testing and treatment as well, whatever your own result now shows. And because syphilis travels in company, testing for other sexually transmitted infections at the same time is standard rather than an extra.
Syphilis is a very treatable infection — treatment is straightforward when it is done correctly. What turns it into a frightening experience is usually not the disease but the test results arriving without an explanation. If you have a positive result and nobody has walked you through what it means, ask. Once you can read your own results, the panic tends to disappear.
إذا كانت لديك مخاوف بشأن نتائج اختبار الدم الخاص بالزهري أو كنت بحاجة إلى التشخيص والعلاج لعدوى منقولة جنسياً، فإن الدكتور سارافي ويراسوبون يقدم استشارات متخصصة وسرية في المقر الرئيسي لمستشفى بانكوك. احجز استشارة. يمكن ترتيب المواعيد في مستشفى سامิติفيج سريراشا من خلال الاتصال بقسم المسالك البولية على 088-022-1445.
الأسئلة المتكررة حول اختبارات دم مرض الزهري
تُستخدم اختبارات اللامولبية (مثل VDRL و RPR) كاختبارات تحري للكشف عن عدوى الزهري النشطة ولمراقبة استجابة العلاج. أما اختبارات المולبية (مثل TP-PA و FTA-ABS) فهي اختبارات تأكيدية عالية التخصص لمرض الزهري، لكنها تظل إيجابية طوال الحياة حتى بعد العلاج الناجح، لذا لا يمكن استخدامها وحدها لتقييم نتيجة العلاج.
يُعد اختبار VDRL أو RPR الإيجابي مؤشراً قوياً ولكنه ليس تشخيصاً قاطعاً. قد تُنتج اختبارات الفحص هذه أحياناً نتائج إيجابية كاذبة بسبب حالات أخرى مثل أمراض المناعة الذاتية أو العدوى الفيروسية. يُطلب دائماً إجراء اختبار تأكيدي لولبي (TP-PA أو FTA-ABS) للوصول إلى تشخيص قاطع لمرض الزهري.
تكتشف اختبارات اللولبيات أجساماً مضادة محددة ضد بكتيريا الزهري تظل موجودة في مجرى الدم مدى الحياة بمجرد إنتاجها، حتى بعد الشفاء التام من العدوى. هذه نتيجة طبيعية ولا تعني أن العدوى لا تزال نشطة. تتم مراقبة نجاح العلاج باستخدام اختبارات غير اللولبيات (VDRL أو RPR)، والتي يجب أن تظهر انخفاضاً في عيار الأجسام المضادة بعد العلاج الفعّال.
يتم تتبع الاستجابة للعلاج من خلال مراقبة عيار اختبار VDRL أو RPR بمرور الوقت. بعد نجاح العلاج، يجب أن ينخفض عيار الاختبار غير اللولبي بمقدار أربعة أضعاف أو أكثر خلال 6 إلى 12 شهرًا. قد يشير عيار الاختبار المستقر أو المتزايد إلى فشل العلاج أو الإصابة مرة أخرى، مما يتطلب تقييمًا إضافيًا من قبل أخصائي.
Yes, syphilis is highly curable, especially when diagnosed and treated early. The standard treatment is penicillin G injection, with the dose and duration depending on the stage of infection. Early diagnosis, correct treatment, and regular follow-up blood tests are essential to ensure complete cure and prevent complications or transmission to partners. Current sexual partners should be tested and treated as well.
إخلاء مسؤولية: This content is written and reviewed by Dr. Soarawee Weerasopone, a board-certified urologist at Bangkok Hospital Headquarters. It is intended for educational purposes only and does not constitute medical advice. Blood test results must be interpreted by a doctor who knows your history — do not draw conclusions about your own results from this article alone. No medical advice, diagnosis or prescription is provided through personal messaging channels. Always consult a qualified healthcare professional before starting any medical treatment.
مكتوب طبياً ومراجع بواسطة: Dr. Soarawee Weerasopone (Dr. Pom) — Board-Certified Urologist, Bangkok Hospital Headquarters, in urological practice since 2016. Fellowship: Robotic Surgery, Chang Gung Memorial Hospital, Taiwan (2019) · Observership: Endourology, Juntendo University Hospital, Tokyo (2022) · Research Scholar & Clinical Observer, Scott Department of Urology, Baylor College of Medicine, USA (2025–2026).

Dr. Soarawee Weerasopone (Dr. Pom) is a board-certified urologist at Bangkok Hospital Headquarters, specializing in Men’s Health, Robotic Surgery (da Vinci Xi) and Kidney Stone treatment. He is currently a Research Scholar and Clinical Observer at the Scott Department of Urology, Baylor College of Medicine (2025–2026), under Prof. Mohit Khera. He completed a Robotic Surgery Fellowship at Chang Gung Memorial Hospital, Taiwan (2019) and an Endourology Observership at Juntendo University Hospital, Tokyo (2022).

